IP Library Granted Patent US 9,549,970
Granted Patent B2
US 9,549,970 · App. 13/798,725 · Granted Jan 24, 2017

Methods for producing yeast-based vaccines

Inventors: Alex Franzusoff (Nahant, MA); Deborah Quick (Louisville, CO)
Assignee: GlobeImmune, Inc.
A61K39/00A61K36/064A61K39/39A61K2039/57C07K2319/00C07K2319/035C12N2760/18634
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,549,970
App. No.
13/798,725
Granted
Jan 24, 2017
Kind
B2
Abstract

The invention provides methods for culturing yeast at a neutral pH level. Yeast cultured under neutral pH conditions exhibit desirable characteristics useful for biological purposes, such as the development of vaccines, prophylactics and therapeutics. The invention also provides for compositions and kits comprising yeast grown using the methodologies disclosed herein.

Claims (23)

1. A method for growing yeast from Saccharomyces cerevisiae that express a heterologous antigen on its surface, internally, or both on its surface and internally, comprising culturing the yeast in a medium that has been maintained at a pH of between 5.5 and 8 for at least 90% of the time the yeast are in culture, and further comprising formulating the antigen-expressing yeast for administration to an individual.

2. The method of claim 1 , further comprising formulating the yeast with a pharmaceutically acceptable excipient.

3. The method of claim 1 , wherein the yeast have been cultured in a medium that has been maintained at a pH of between 6 and 8 for at least 90% of the time the yeast are in culture.

4. The method of claim 1 , wherein the yeast are cultured in a medium wherein the pH of the medium does not drop below pH 5.5 while the yeast are in culture.

5. The method of claim 1 , wherein the medium is buffered with a buffering agent.

6. The method of claim 1 , wherein the medium is buffered with Bis-Tris.

7. The method of claim 1 , wherein the medium is buffered with succinate or succinic acid.

8. The method of claim 1 , wherein the medium is buffered with citrate.

9. The method of claim 1 , wherein the medium is buffered with phosphate.

10. The method of claim 1 , wherein the heterologous antigen is expressed on the surface of the yeast.

11. The method of claim 1 , further comprising lyophilizing the yeast.

12. The method of claim 1 , wherein the medium is U2 medium or UL2 medium.

13. A method for growing yeast from Saccharomyces that express a heterologous antigen on its surface, internally, or both on its surface and internally, comprising culturing the yeast in a medium that has been maintained at a pH of between 5.5 and 8 for the entire time the yeast are in culture, and further comprising formulating the antigen-expressing yeast for administration to an individual.

14. The method of claim 13 , wherein the medium has been maintained at a pH of between 6 and 8 for the entire time the yeast are in culture.

15. The method of claim 13 , wherein the medium is buffered with a buffering agent.

16. The method of claim 13 , wherein the medium is buffered with Bis-Tris.

17. The method of claim 13 , wherein the medium is buffered with succinate or succinic acid.

18. The method of claim 13 , wherein the medium is buffered with citrate.

19. The method of claim 13 , wherein the medium is buffered with phosphate.

20. The method of claim 13 , further comprising lyophilizing the yeast.

21. A method for growing yeast from Saccharomyces that express a heterologous antigen on its surface, internally, or both on its surface and internally, comprising growing and maintaining the yeast in a buffered medium, wherein the pH of the medium does not drop below pH 5.5 from the start of yeast growth to harvest of the yeast, and further comprising formulating the antigen-expressing yeast for administration to an individual.

22. The method of claim 21 , wherein the medium is buffered with a buffering agent.

23. The method of claim 21 , further comprising lyophilizing the yeast.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 16, 2014
From: FRANZUSOFF, ALEX; QUICK, DEBORAH
To: GLOBEIMMUNE, INC.
Reel/Frame 031989/0969 →
Continuity (3)
Continuation 12525045
Provisional Application 60899281 · Feb 2, 2007
Related Publication 20130309269A1 · Nov 21, 2013